193 related articles for article (PubMed ID: 33598567)
1. Does the effectiveness of IUI in couples with unexplained subfertility depend on their prognosis of natural conception? A replication of the H2Oil study.
van Eekelen R; Rosielle K; van Welie N; Dreyer K; van Wely M; Mol BW; Eijkemans MJ; Mijatovic V; van Geloven N
Hum Reprod Open; 2020; 2020(4):hoaa047. PubMed ID: 33598567
[TBL] [Abstract][Full Text] [Related]
2. Is IUI with ovarian stimulation effective in couples with unexplained subfertility?
van Eekelen R; van Geloven N; van Wely M; McLernon DJ; Mol F; Custers IM; Steures P; Bhattacharya S; Mol BW; van der Veen F; Eijkemans MJ
Hum Reprod; 2019 Jan; 34(1):84-91. PubMed ID: 30395266
[TBL] [Abstract][Full Text] [Related]
3. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.
Wessel JA; Mochtar MH; Besselink DE; Betjes H; de Bruin JP; Cantineau AEP; Groenewoud ER; Hooker AB; Lambalk CB; Kwee J; Kaaijk EM; Louwé LA; Maas JWM; Mol BWJ; van Rumste MME; Traas MAF; Goddijn M; van Wely M; Mol F
Hum Reprod; 2022 Nov; 37(12):2808-2816. PubMed ID: 36331493
[TBL] [Abstract][Full Text] [Related]
4. Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials.
Wessel JA; Mol F; Danhof NA; Bensdorp AJ; Tjon-Kon Fat RI; Broekmans FJM; Hoek A; Mol BWJ; Mochtar MH; van Wely M;
Hum Reprod; 2021 Feb; 36(3):817-825. PubMed ID: 33347597
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
van Eekelen R; Eijkemans MJ; Mochtar M; Mol F; Mol BW; Groen H; van Wely M
Hum Reprod; 2020 Sep; 35(9):2037-2046,. PubMed ID: 32876323
[TBL] [Abstract][Full Text] [Related]
6. Natural conception rates in couples with unexplained or mild male subfertility scheduled for fertility treatment: a secondary analysis of a randomized controlled trial.
van Eekelen R; Tjon-Kon-Fat RI; Bossuyt PMM; van Geloven N; Eijkemans MJC; Bensdorp AJ; van der Veen F; Mol BW; van Wely M
Hum Reprod; 2018 May; 33(5):919-923. PubMed ID: 29538638
[TBL] [Abstract][Full Text] [Related]
7. Treatment effect of oil-based contrast is related to experienced pain at HSG: a post-hoc analysis of the randomised H2Oil study.
van Welie N; Dreyer K; van Rijswijk J; Verhoeve HR; Goddijn M; Nap AW; Smeenk JMJ; Traas MAF; Rijnsaardt-Lukassen HGM; van Dongen AJCM; Bourdrez P; de Bruin JP; Sluijmer AV; Gijsen AP; van de Ven PM; Lambalk CB; Mijatovic V; Mol BWJ
Hum Reprod; 2019 Dec; 34(12):2391-2398. PubMed ID: 31887222
[TBL] [Abstract][Full Text] [Related]
8. Predicting the chances of having a baby with or without treatment at different time points in couples with unexplained subfertility.
McLernon DJ; Lee AJ; Maheshwari A; van Eekelen R; van Geloven N; Putter H; Eijkemans MJ; van der Steeg JW; van der Veen F; Steyerberg EW; Mol BW; Bhattacharya S
Hum Reprod; 2019 Jun; 34(6):1126-1138. PubMed ID: 31119290
[TBL] [Abstract][Full Text] [Related]
9. Thyroid function in neonates conceived after hysterosalpingography with iodinated contrast.
van Welie N; Roest I; Portela M; van Rijswijk J; Koks C; Lambalk CB; Dreyer K; Mol BWJ; Finken MJJ; Mijatovic V;
Hum Reprod; 2020 May; 35(5):1159-1167. PubMed ID: 32427280
[TBL] [Abstract][Full Text] [Related]
10. Tubal flushing with oil- or water-based contrast medium: can we identify markers that indicate treatment benefit?
van Rijswijk J; van Welie N; Dreyer K; Tajik P; Lambalk CB; Hompes P; Mijatovic V; Mol BWJ; Zafarmand MH
Hum Reprod Open; 2019; 2019(3):hoz015. PubMed ID: 31334364
[TBL] [Abstract][Full Text] [Related]
11. Hysterosalpingo-foam sonography versus hysterosalpingography during fertility work-up: an economic evaluation alongside a randomized controlled trial.
Kamphuis D; van Eekelen R; van Welie N; Dreyer K; van Rijswijk J; van Hooff MHA; de Bruin JP; Verhoeve HR; Mol F; van Baal WM; Traas MAF; van Peperstraten AM; Manger AP; Gianotten J; de Koning CH; Koning AMH; Bayram N; van der Ham DP; Vrouenraets FPJM; Kalafusova M; van de Laar BIG; Kaijser J; Lambeek AF; Meijer WJ; Broekmans FJM; Valkenburg O; van der Voet LF; van Disseldorp J; Lambers MJ; Tros R; Lambalk CB; Stoker J; van Wely M; Bossuyt PMM; Mol BWJ; Mijatovic V
Hum Reprod; 2024 Jun; 39(6):1222-1230. PubMed ID: 38600625
[TBL] [Abstract][Full Text] [Related]
12. IVF for unexplained subfertility; whom should we treat?
van Eekelen R; van Geloven N; van Wely M; Bhattacharya S; van der Veen F; Eijkemans MJ; McLernon DJ
Hum Reprod; 2019 Jul; 34(7):1249-1259. PubMed ID: 31194864
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.
van Eekelen R; Wang R; Danhof NA; Mol F; Mochtar M; Mol BW; van Wely M
Hum Reprod; 2021 Apr; 36(5):1288-1295. PubMed ID: 33615360
[TBL] [Abstract][Full Text] [Related]
14. Endometrial thickness as a biomarker for ongoing pregnancy in IUI for unexplained subfertility: a secondary analysis.
Danhof NA; van Eekelen R; Repping S; Mol BWJ; van der Veen F; van Wely M; Mochtar MH;
Hum Reprod Open; 2020; 2020(1):hoz024. PubMed ID: 31934648
[TBL] [Abstract][Full Text] [Related]
15. Can hysterosalpingo-foam sonography replace hysterosalpingography as first-choice tubal patency test? A randomized non-inferiority trial.
van Welie N; van Rijswijk J; Dreyer K; van Hooff MHA; de Bruin JP; Verhoeve HR; Mol F; van Baal WM; Traas MAF; van Peperstraten AM; Manger AP; Gianotten J; de Koning CH; Koning AMH; Bayram N; van der Ham DP; Vrouenraets FPJM; Kalafusova M; van de Laar BIG; Kaijser J; Lambeek AF; Meijer WJ; Broekmans FJM; Valkenburg O; van der Voet LF; van Disseldorp J; Lambers MJ; Tros R; Lambalk CB; Stoker J; van Wely M; Bossuyt PMM; Mol BWJ; Mijatovic V
Hum Reprod; 2022 May; 37(5):969-979. PubMed ID: 35220432
[TBL] [Abstract][Full Text] [Related]
16. The cost-effectiveness of transvaginal hydrolaparoscopy versus hysterosalpingography in the work-up for subfertility.
van Kessel MA; Pham CT; Tros R; Oosterhuis GJE; Kuchenbecker WKH; Bongers MY; Mol BWJ; Koks CAM
Hum Reprod; 2022 Nov; 37(12):2768-2776. PubMed ID: 36223599
[TBL] [Abstract][Full Text] [Related]
17. IVF or IUI as first-line treatment in unexplained subfertility: the conundrum of treatment selection markers.
Tjon-Kon-Fat RI; Tajik P; Zafarmand MH; Bensdorp AJ; Bossuyt PMM; Oosterhuis GJE; van Golde R; Repping S; Lambers MDA; Slappendel E; Perquin D; Pelinck MJ; Gianotten J; Maas JWM; Eijkemans MJC; van der Veen F; Mol BW; van Wely M;
Hum Reprod; 2017 May; 32(5):1028-1032. PubMed ID: 28333222
[TBL] [Abstract][Full Text] [Related]
18. Age-related natural fertility outcomes in women over 35 years: a systematic review and individual participant data meta-analysis.
Chua SJ; Danhof NA; Mochtar MH; van Wely M; McLernon DJ; Custers I; Lee E; Dreyer K; Cahill DJ; Gillett WR; Righarts A; Strandell A; Rantsi T; Schmidt L; Eijkemans MJC; Mol BWJ; van Eekelen R
Hum Reprod; 2020 Aug; 35(8):1808-1820. PubMed ID: 32696041
[TBL] [Abstract][Full Text] [Related]
19. Natural conception: repeated predictions over time.
van Eekelen R; Scholten I; Tjon-Kon-Fat RI; van der Steeg JW; Steures P; Hompes P; van Wely M; van der Veen F; Mol BW; Eijkemans MJ; Te Velde ER; van Geloven N
Hum Reprod; 2017 Feb; 32(2):346-353. PubMed ID: 27993999
[TBL] [Abstract][Full Text] [Related]
20. External validation of a dynamic prediction model for repeated predictions of natural conception over time.
van Eekelen R; McLernon DJ; van Wely M; Eijkemans MJ; Bhattacharya S; van der Veen F; van Geloven N
Hum Reprod; 2018 Dec; 33(12):2268-2275. PubMed ID: 30358841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
